China’s new drug approvals take market scale beyond US$13 billion as innovation picks up

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

China has already approved nearly thrice the number of innovative drugs than in the 13th five-year plan, Shanghai forum hears.